[Georgia] Updates to Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines
Carelon Medical Benefits Management updated clinical appropriateness guidelines effective November 15, 2026, with major changes to vascular procedures (adding new ablation modalities, revising criteria for embolization), PFO closure (age-based restrictions), and genetic/molecular testing for cancer (expanding indications for liquid biopsy, somatic tumor testing, and tissue-based molecular profiling across multiple cancer types). Billing teams must review affected procedure approvals and update documentation requirements for cancer-related genetic testing.